175 filings
Page 4 of 9
8-K
upoet1c
5 Aug 21
AVROBIO Reports Second Quarter 2021 Financial Results and Provides Business Update
7:28am
8-K
7943zs ui
17 Jun 21
Other Events
8:17am
8-K
syfnod jx1u2gnm705u
14 Jun 21
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
vbaps 0b4
13 May 21
AVROBIO Reports First Quarter 2021 Financial Results and Provides Business Update
7:15am
8-K
muvsiefraw1bk
3 May 21
AVROBIO Provides Regulatory Update on Investigational AVR-RD-01
7:24am
DEFA14A
uoso6kfa7xqqpg fku8
22 Apr 21
Additional proxy soliciting materials
4:45pm
8-K
aq0o5z uc1af5
23 Mar 21
Regulation FD Disclosure
8:03am
S-8
nckrk9 i8y1u4
18 Mar 21
Registration of securities for employees
5:25pm
8-K
8l9wyi6f6ekaa
18 Mar 21
AVROBIO Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Update
7:06am
8-K
wexa8tu3 14hx2xjzlbt
8 Feb 21
Regulation FD Disclosure
7:57am
8-K
igspxbou6yjzy5qv
11 Jan 21
Regulation FD Disclosure
7:01am
8-K
aj89qc2kwki65kys0
20 Nov 20
AVROBIO Announces Proposed Public Offering of Common Stock
4:08pm
424B5
8vvn zdoo
20 Nov 20
Prospectus supplement for primary offering
4:03pm
424B5
4z67 7zweia4h
19 Nov 20
Prospectus supplement for primary offering
4:15pm
8-K
6qim9y3vck2sp
17 Nov 20
Other Events
9:07am
8-K
n8asra8jm h6ghyejxi
17 Nov 20
Three months post-gene therapy, first patient in Gaucher trial shows reductions in the toxic metabolite
7:39am